#17 Why we need vaccine surveillance systems ...

Send a message to the show!Pharmacovigilance has traditionally focused on the patient at the receiving end of a medicine. But what happens to medicines once they leave the body? In this episode, Valentina Giunchi and Joe Mitchell unpack the emerging field of ecopharmacovigilance ...  Show more

Send a message to the show!For all its ease and speed, disproportionality analysis can be distorted by many biases, making it easy to misuse and misinterpret. Michele Fusaroli from Uppsala Monitoring Centre and Eugene van Puijenbroek from the Netherlands pharmacovigilance centre ...  Show more

In this podcast, Dr Emma Nash talks to Professor Tony Avery, GP, Professor of Primary Health Care at the University of Nottingham, and National Clinical Director for Prescribing. Key points from the two prescribing safety modules are touched on, in the context of the Medicines Sa ...  Show more

We begin with a discussion about our article of the week from the BMJ, entitled prenatal opioid exposure and subsequent risk of neuropsychiatric disorders in children: nationwide birth cohort study in South Korea.

In the second half, we start off by talking about the ri ...

Behnaz Sarrami, MS, PharmD, a PGx for pharmacists podcast, joins Cari Lalande, PharmD where we discuss the clinical value and utility of PGx and how it can be implemented in a clinical setting. See omnystudio.com/listener for privacy information. Learn more about your ad choices. ...  Show more

JAMA Associate Editor Ethan Basch, MD, and Melanie Calvert, PhD, from the University of Birmingham, UK, discuss barriers to and strategies for including rigorous patient-reported outcomes in clinical trials, and reflect on Dr Calvert's recent JAMA paper on related ethical impl ...